Share price change in select U.S.-listed Chinese biopharma companies 2022
On March 10, 2022, Chinese biopharmaceutical company I-Mab saw its share price drop by nearly 14 percentage points in U.S. stock exchange markets, while Zai Lab similarly saw its share price decrease by some nine percentage points. This statistc illustrates the share price change in select Chinese companies listed in the United States.
